Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).

[1]  B. Rasmussen,et al.  The Danish Neuro-Oncology Registry: establishment, completeness and validity , 2016, BMC Research Notes.

[2]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[3]  O. Visser,et al.  Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. , 2015, European journal of cancer.

[4]  R. Henriksson,et al.  Brain tumors in Sweden: Data from a population-based registry 1999–2012 , 2015, Acta oncologica.

[5]  R. Marcos-Gragera,et al.  Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era. , 2014, Cancer epidemiology.

[6]  A. Olschowski,et al.  Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry , 2013, British Journal of Cancer.

[7]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[8]  M. Sant,et al.  Survival of European patients with central nervous system tumors , 2012, International journal of cancer.

[9]  Damien C Weber,et al.  Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.

[10]  Janez Stare,et al.  On Estimation in Relative Survival , 2012, Biometrics.

[11]  G. Kantor,et al.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. , 2011, Neuro-oncology.

[12]  M. Geraci,et al.  Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. , 2010, European journal of cancer.

[13]  J. Birch,et al.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. , 2009, Neuro-oncology.

[14]  C. Saurina,et al.  Accurately estimating breast cancer survival in Spain: cross-matching local cancer registries with the National Death Index. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[15]  H. Heinzl,et al.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.

[16]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[17]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[18]  Timothy C Ryken,et al.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.

[19]  F. Langmark,et al.  Trends in Incidence of Brain and Central Nervous System Tumors in Norway, 1970–1999 , 2004, Neuroepidemiology.

[20]  F. Davis,et al.  The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States , 1999, Cancer Causes & Control.

[21]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[22]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. , 2016, Neuro-oncology.

[23]  A. Niemierko,et al.  Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. , 2016, Journal of neurosurgery.

[24]  P. Wen,et al.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review , 2014 .

[25]  C. Kruchko,et al.  The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends. , 2013, Journal of registry management.

[26]  R. Marcos-Gragera,et al.  Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994–2005 , 2010, Journal of Neuro-Oncology.